| 注册
首页|期刊导航|中国全科医学|肿瘤溶解综合征高危患者的诊治进展

肿瘤溶解综合征高危患者的诊治进展

陈星华 丁国华

中国全科医学2012,Vol.15Issue(6):596-598,3.
中国全科医学2012,Vol.15Issue(6):596-598,3.

肿瘤溶解综合征高危患者的诊治进展

Advances in Diagnosis and Treatment of High Risk Tumor Lysis Syndrome Patients

陈星华 1丁国华1

作者信息

  • 1. 430060,湖北省武汉市,武汉大学人民医院肾内科
  • 折叠

摘要

Abstract

Objective Tumor lysis syndrome ( TLS ) is characterized by a group of metabolic derangements caused by the massive and abrupt release of cellular components into the blood after the rapid lysis of malignant cells. The metabolic derangements include hyperuricemia, hyperpotassaemia, hyperphosphatemia, hypocalcemia and acute renal insufficiency. The most important therapy of TLS is precaution, once TLS is discovered in time and treatment in the earlier period, most TLS can be eusemia. But for the high risk TLS patients, even though precautions are administration, some patients still develop to severe situation , even to death. This article reviews recent researches and developments of the pathophysiology, risk factors, risk grading, prophylaxis and treatment of high risk TLS patients.

关键词

肿瘤溶解综合征/诊断/治疗

Key words

Tumor lysis syndrome/Diagnosis/Therapy

分类

医药卫生

引用本文复制引用

陈星华,丁国华..肿瘤溶解综合征高危患者的诊治进展[J].中国全科医学,2012,15(6):596-598,3.

中国全科医学

OA北大核心CSCDCSTPCD

1007-9572

访问量0
|
下载量0
段落导航相关论文